Chimeric molecule IL‐6/soluble IL‐6 receptor is a potent mitogen for fetal hepatocytes

A novel recombinant molecule, termed IL‐6c and consisting of a chimera of interleukin 6 (IL‐6) and its soluble receptor is extremely potent in stimulating proliferation of hematopoietic progenitors. We investigated the effect of the IL‐6c on the proliferation and differentiation of E14 fetal hepatocytes. IL‐6c, in a dose‐dependent manner, stimulated proliferation of E14 fetal rat hepatocytes. Adult hepatocyte mitogens together with IL‐6c showed no further effect on proliferation. Hematopoietic stem cells mitogens SCF and flt3 ligand (FL) were also mitogenic for fetal hepatocytes, but did not further enhance the effect of IL‐6c on cell proliferation. IL‐6c decreased expression of fetal markers α‐fetoprotein (AFP) and gamma‐glutamyltranspeptidase, and induced expression of adult enzyme glucose‐6‐phosphatase (Gluc‐6‐P) in E14 hepatocytes. On the other hand, IL‐6c strongly reduced, in a dose‐dependant manner, expression of albumin and tyrosine aminotransferase (TAT). However, when the cells were grown for 3 days with IL‐6c, and IL‐6c was removed for the next 5 days, expression of albumin and TAT returned to levels found in control cultures. In conclusion, IL‐6c stimulated proliferation and affected gene expression in fetal hepatocytes in culture. © 2004 Wiley‐Liss, Inc.

[1]  P. Schirmacher,et al.  Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration. , 2000, Gastroenterology.

[2]  S. Rose-John,et al.  Liver regeneration induced by a designer human IL‐6/ sIL‐6R fusion protein reverses severe hepatocellular injury , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  R. V. van Etten,et al.  Modulation of hepatic acute phase gene expression by epidermal growth factor and src protein tyrosine kinases in murine and human hepatic cells , 1999, Hepatology.

[4]  A. Nagler,et al.  The soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro maintenance and proliferation of human CD34(+)CD38(-/low) cells capable of repopulating severe combined immunodeficiency mice. , 1999, Blood.

[5]  Yoshiaki Ito,et al.  Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer , 1999, The EMBO journal.

[6]  L. Reid,et al.  Expansion Conditions for Early Hepatic Progenitor Cells from Embryonal and Neonatal Rat Livers , 1999, Digestive Diseases and Sciences.

[7]  A. Demetris,et al.  Mitosis and apoptosis in the liver of interleukin‐6–deficient mice after partial hepatectomy , 1999, Hepatology.

[8]  J. Chebath,et al.  Increased sensitivity of IL-6-deficient mice to carbon tetrachloride hepatotoxicity and protection with an IL-6 receptor-IL-6 chimera. , 1998, Cytokines, cellular & molecular therapy.

[9]  S. Rose-John,et al.  Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. , 1998, Blood.

[10]  J. Bruix,et al.  Tumor necrosis factor primes hepatocytes for DNA replication in the rat , 1998, Hepatology.

[11]  P. Musiani,et al.  Coexpression of IL‐6 and soluble IL‐6R causes nodular regenerative hyperplasia and adenomas of the liver , 1998, The EMBO journal.

[12]  P. Schirmacher,et al.  Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice. , 1998, The American journal of pathology.

[13]  A. Nagler,et al.  Interleukin-6 receptor-interleukin-6 fusion proteins with enhanced interleukin-6 type pleiotropic activities. , 1997, European cytokine network.

[14]  S. Thorgeirsson,et al.  Coexpression of flt-3 ligand/flt-3 and SCF/c-kit signal transduction system in bile-duct-ligated SI and W mice. , 1997, The American journal of pathology.

[15]  J. Peschon,et al.  Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Rose-John,et al.  A bioactive designer cytokine for human hematopoietic progenitor cell expansion , 1997, Nature Biotechnology.

[17]  E. Furth,et al.  Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice , 1996, Science.

[18]  G. Michalopoulos,et al.  Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium , 1996, The Journal of cell biology.

[19]  M. Benito,et al.  Regulation of gene expression by interleukin‐6 in fetal rat hepatocyte primary cultures: Role of epidermal growth factor and dexamethasone , 1995, Hepatology.

[20]  J. Lemire,et al.  Multiple alpha-fetoprotein RNAs in adult rat liver: cell type-specific expression and differential regulation. , 1991, Cancer research.

[21]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[22]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[23]  A. Seligman,et al.  HISTOCHEMICAL AND ULTRASTRUCTURAL DEMONSTRATION OF γ-GLUTAMYL TRANSPEPTIDASE ACTIVITY , 1969 .

[24]  S. Rose-John,et al.  Interleukin-6 and Soluble Interleukin-6 Receptor : Direct Stimulation of gp 130 and Hematopoiesis , 1998 .